Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT07098156
Eligibility Criteria:
Inclusion Criteria:
Healthy Autistic Individuals (Autistic Controls) must:
* Be aged 25-45 years
* Be Autistic (clinically diagnosed and/or have an Autism Quotient (AQ-10) score of ≥6)
* Be able to provide informed consent for the study
* Be able to read, understand and respond to questionnaires in English
* Have no history of an eating disorder
* Willing to have an MRI scan in Aberdeen
Autistic Individuals with anorexia nervosa must:
* Be aged 25-45 years
* Be Autistic (clinically diagnosed and/or have an AQ-10 score of ≥6)
* Be able to provide informed consent to the study
* Be able to read, understand and respond to questionnaires in English
* Have a diagnosis of anorexia nervosa or a body mass index of \<18.5
* Willing to have an MRI scan in Aberdeen
Exclusion Criteria:
Individuals are not eligible for the study if they:
* Are aged \<25 or \>45 years
* Are not Autistic or not clinically diagnosed as Autistic and have an AQ-10 score of \<6
* Are diagnosed with an eating disorder other than anorexia nervosa
* Have a history of brain injury (e.g., stroke)
* Be unable to provide informed consent for the study
* Have contraindications to MRI scanning, such has implantable cardiac devices
* Are unable to read, understand and respond to questionnaires in English
* As participants will need to consent to the study and complete questionnaires by themselves, individuals with intellectual disability will be excluded from this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
45 Years
Study:
NCT07098156
Study Brief:
Protocol Section:
NCT07098156